Source: Cancer Research UK
Date of publication: November 2011
Publication type: News item
In a nutshell: Research published in the Lancet Oncology says the human papillomavirus (HPV) vaccine Cervarix “offers excellent protection” against serious cell changes that lead to cervical cancer, particularly when given to young adolescent girls before they become sexually active.
Length of publication: Webpage
Posted by Emily Hopkins 
